High Throughput Viability Assay for Microbiology
C. T. Meyer, G. K. Lynch, D. F. Stamo, E. J. Miller, A. Chatterjee, J. M. Kralj
The paper introduces a high-throughput viability assay, GVA, that reduces time and resources compared to traditional CFU methods, enabling large-scale drug screening and discovery.
bioRxiv · Jan 4, 2023 · PreprintMicrobiology